Li, Dapeng
Martinez, David R. http://orcid.org/0000-0002-2940-8961
Schäfer, Alexandra http://orcid.org/0000-0002-4760-4923
Chen, Haiyan
Barr, Maggie
Sutherland, Laura L.
Lee, Esther
Parks, Robert
Mielke, Dieter http://orcid.org/0000-0003-2182-0510
Edwards, Whitney
Newman, Amanda
Bock, Kevin W. http://orcid.org/0000-0001-9454-0937
Minai, Mahnaz
Nagata, Bianca M.
Gagne, Matthew http://orcid.org/0000-0001-5526-6162
Douek, Daniel C.
DeMarco, C. Todd
Denny, Thomas N.
Oguin, Thomas H. III
Brown, Alecia
Rountree, Wes
Wang, Yunfei
Mansouri, Katayoun
Edwards, Robert J. http://orcid.org/0000-0003-4446-1194
Ferrari, Guido
Sempowski, Gregory D. http://orcid.org/0000-0003-0391-6594
Eaton, Amanda http://orcid.org/0000-0003-3064-2947
Tang, Juanjie
Cain, Derek W.
Santra, Sampa http://orcid.org/0000-0002-8796-1714
Pardi, Norbert
Weissman, Drew
Tomai, Mark A.
Fox, Christopher B.
Moore, Ian N.
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Golding, Hana
Seder, Robert http://orcid.org/0000-0003-3133-0849
Khurana, Surender http://orcid.org/0000-0002-0593-7965
Baric, Ralph S. http://orcid.org/0000-0001-6827-8701
Montefiori, David C.
Saunders, Kevin O. http://orcid.org/0000-0001-7399-7954
Haynes, Barton F.
Article History
Received: 20 June 2022
Accepted: 11 October 2022
First Online: 23 October 2022
Competing interests
: B.F.H. and K.O.S. have filed US patents regarding the nanoparticle vaccine, M.A.T. and the 3M company have US patents filed on 3M-052, and C.B.F. and IDRI have filed a patent on the formulation of 3M-052-AF and 3M-052-Alum. The 3M company had no role in the execution of the study, data collection or data interpretation. D.W. is named on US patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins. D.W. and N.P. are also named on a US patent describing the use of nucleoside-modified mRNA in lipid nanoparticles as a vaccine platform. All other authors declare no competing interests.